Mode
Text Size
Log in / Sign up

High mammography awareness and partner support are linked to breast cancer screening behaviorsMen and Women Show Mixed Awareness of Breast Cancer Screening

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that while awareness of mammography is high, lack of symptoms remains a primary barrier to regular screening.

This cross-sectional study evaluates breast cancer awareness, screening behaviors, and the role of male partners in supporting women's health in Turkey. The survey included 725 participants to identify common barriers to screening and assess knowledge regarding risk factors and symptoms.

Key findings indicate that 90.5% of women recognized that mammography enables early detection, and 69.6% of women aged 40 years or older had undergone at least one mammogram. Screening uptake was significantly higher in those with a family or social history of breast cancer (70.6%) compared to those without (29.4%, p = 0.002). While 81.0% of women performed some form of self-examination, only 22.9% performed it monthly as recommended.

Regarding barriers, the absence of symptoms was the most frequent reported barrier at 56.0%, followed by negligence (30.3%) and difficulties accessing healthcare services (17.1%). Additionally, 87.8% of men reported supporting their partners' participation in screening. The study utilized a convenience sampling approach, which may limit the generalizability of the findings.

How this fits prior evidence

This cross-sectional study addresses gaps in understanding patient perceptions and behavioral barriers to breast cancer screening. While it does not directly relate to the technical advancements in imaging or biomarker analysis seen in prior coverage, such as ctDNA dynamics or XAI in ultrasound, it provides data on the social and educational factors influencing early detection and screening uptake.

A survey of 725 people in Turkey looked at how well men and women understand breast cancer. The study found that while 90.5% of women knew mammograms could help detect cancer early, many still face hurdles. For example, about 69.6% of women aged 40 and older had received at least one mammogram.

Several factors influence whether a woman gets screened. Those with a family or social history of breast cancer were much more likely to get tested than those without such a history. However, many women reported that a lack of symptoms was the main reason they did not seek screening, followed by personal negligence and difficulty accessing healthcare services.

While 81% of women performed some form of self-examination, only about 22.9% did so every month as recommended. On the other side, the study found that 87.8% of men reported they would support their partners in participating in screenings. Because this was a one-time survey using a convenience sample, the results show links rather than direct causes for these behaviors.

What this means for you:
Many women know mammograms are important, but lack of symptoms and other barriers still affect screening rates.

Common questions

What are the main reasons women might skip breast cancer screenings?

The most common reason reported for not getting screened was a lack of symptoms, which was cited by 56.0% of participants. Other barriers included personal negligence at 30.3% and difficulties accessing healthcare services at 17.1%.

How often do women perform breast self-examinations?

The study found that 81.0% of women performed some type of breast self-examination. However, only 22.9% of those women performed the exam on a monthly basis as recommended by health guidelines.

Do men support their partners in getting screened?

The study found that 87.8% of men reported that they would support their partners' participation in breast cancer screening programs.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundBreast cancer is the most common cancer among women worldwide. Despite the availability of screening services, participation remains suboptimal in Türkiye, and evidence on the determinants of screening behaviors and men’s supportive role is limited. This study aimed to assess BC awareness among women and men, identify factors associated with screening behaviors, and explore men’s attitudes toward supporting their partners’ participation in screening.MethodsA cross-sectional survey was conducted between June 2022 and December 2024 using a convenience sampling approach among 725 participants at Koç University Hospital and affiliated institutions. The questionnaire developed by the authors based on a literature review was administered either in person or via email. Sociodemographic characteristics, health literacy, knowledge of risk factors and symptoms, screening behaviors, and self-breast examination practices were assessed through structured questionnaires.ResultsKnowledge of breast cancer screening was high, with 90.5% of women recognizing that mammography enables early detection. However, among women aged ≥40 years, only 69.6% had undergone at least one mammogram. Screening uptake was significantly higher among women with a family or social history of breast cancer than among those without (70.6% vs. 29.4%, p = 0.002). The most frequently reported barriers to screening were the absence of symptoms (56.0%), negligence (30.3%), and difficulties accessing healthcare services (17.1%). Although 81.0% of women reported performing breast self-examination, only 22.9% did so monthly, as recommended. Among men, awareness of breast cancer symptoms was moderate, while 87.8% reported supporting their partners’ participation in screening.ConclusionImproving access to screening services and addressing barriers such as neglect and the absence of symptoms may increase breast cancer screening uptake in Türkiye. Engaging partners and families in awareness initiatives could further support participation and facilitate earlier detection.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.